Corvallis, Oregon

Sarepta Therapeutics to Announce Second Quarter 2021 Financial Results and Recent Corporate Developments on August 4, 2021

Retrieved on: 
Wednesday, July 28, 2021

CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, August 4, 2021.

Key Points: 
  • CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, August 4, 2021.
  • E.T., the Company will host a conference call to discuss its second quarter 2021 financial results and to provide a corporate update.
  • Please specify to the operator that you would like to join the "Sarepta Second Quarter 2021 Earnings Call."
  • Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.

The Green Room Opens its Third Cannabis Store in Corvallis, Oregon

Retrieved on: 
Wednesday, May 5, 2021

b'CORVALLIS, Ore., May 5, 2021 /PRNewswire/ --Today, The Green Room announced the grand opening of a third store in Corvallis at 1665 SW 3rd St.

Key Points: 
  • b'CORVALLIS, Ore., May 5, 2021 /PRNewswire/ --Today, The Green Room announced the grand opening of a third store in Corvallis at 1665 SW 3rd St.
  • With a focus on quality products, each store is dedicated to providing its customers with the right product for the right situation.\nService-oriented local business Green Room owner takes pride in providing his customers with a quick, smooth path to service.
  • Opening a third store is a dream come true, not only for myself but also our dedicated employees.
  • "\nThe Green Room was founded with a vision of bridging the gap between cannabis and the public.

Suraj Kulkarni of Corvallis, Oregon named one of America's top 10 youth volunteers of 2021 by the Prudential Spirit of Community Awards

Retrieved on: 
Monday, May 3, 2021

b'NEWARK, N.J., May 3, 2021 /PRNewswire/ --Suraj Kulkarni, 18, of Corvallis, Oregon, was named one of America\'s top 10 youth volunteers of 2021 on Sunday evening by The Prudential Spirit of Community Awards during the program\'s 26th annual, and second fully virtual, national recognition celebration.

Key Points: 
  • b'NEWARK, N.J., May 3, 2021 /PRNewswire/ --Suraj Kulkarni, 18, of Corvallis, Oregon, was named one of America\'s top 10 youth volunteers of 2021 on Sunday evening by The Prudential Spirit of Community Awards during the program\'s 26th annual, and second fully virtual, national recognition celebration.
  • As a result, "I felt ashamed of my own culture and heritage," he said.
  • Suraj and his team also established a presence on Instagram, and started hosting online awareness conferences to connect students all over the world.
  • Reflecting its long-standing commitment to student leadership development, NASSP administers theNational Honor Society,National Junior Honor Society,National Elementary Honor Society, andNational Student Council.

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, April 30, 2021

b"CAMBRIDGE, Mass., April 30, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Apr.

Key Points: 
  • b"CAMBRIDGE, Mass., April 30, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Apr.
  • 30, 2021 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta\xe2\x80\x99s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 4 individuals hired by Sarepta in April 2021.
  • The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).\nThe employees received, in the aggregate, options to purchase 8,615 shares of Sarepta's common stock, and in the aggregate 3,275 restricted stock units (\xe2\x80\x9cRSUs\xe2\x80\x9d).
  • The options have an exercise price of $70.84 per share, which is equal to the closing price of Sarepta's common stock on Apr.

Sarepta Therapeutics to Announce First Quarter 2021 Financial Results and Recent Corporate Developments on May 5, 2021

Retrieved on: 
Wednesday, April 28, 2021

b'CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, May 5, 2021.

Key Points: 
  • b'CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, May 5, 2021.
  • E.T., the Company will host a conference call to discuss its first quarter 2021 financial results and to provide a corporate update.\nThe conference call may be accessed by dialing (844) 534-7313 for domestic callers and (574) 990-1451 for international callers.
  • Please specify to the operator that you would like to join the "Sarepta First Quarter 2021 Earnings Call."
  • We encourage investors and potential investors to consult our website regularly for important information about us.\n'

International Cannabis Lifestyle Brand COOKIES Launches Second Oregon Location in Corvallis

Retrieved on: 
Wednesday, April 7, 2021

International cannabis and lifestyle brand COOKIES is launching its second Oregon location on April 8 in Corvallis.

Key Points: 
  • International cannabis and lifestyle brand COOKIES is launching its second Oregon location on April 8 in Corvallis.
  • Corvallis was his home for four years while he attended and played basketball for Oregon State University.
  • The basketball star is the inspiration for COOKIES Gary Payton strain, one of the brands most popular flower strains, which launched in 2019.
  • Today, COOKIES is one of the most well-respected and top-selling cannabis brands in California and throughout the world.

Sarepta Therapeutics Announces Fourth Year of Route 79, The Duchenne Scholarship Program

Retrieved on: 
Tuesday, March 23, 2021

CAMBRIDGE, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the website for Route 79, The Duchenne Scholarship Program, is officially open and accepting applications.

Key Points: 
  • CAMBRIDGE, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the website for Route 79, The Duchenne Scholarship Program, is officially open and accepting applications.
  • The Route 79 program is designed to help students with Duchenne pursue their post-secondary educational goals.
  • We are thrilled to be launching Route 79, The Duchenne Scholarship Program, for the fourth year.
  • Previous recipients of Route 79 scholarships are eligible to apply for the 2021 Scholarship Program and prior recognition in the Program will have no bearing on 2021 applications.

Sarepta Therapeutics to Present at Upcoming Investor Conferences

Retrieved on: 
Wednesday, February 24, 2021

CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:

Key Points: 
  • CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:
    Cowen 41st Annual Health Care Conference on Wednesday, Mar.
  • The presentations will be webcast live under the investor relations section of Sareptas website at www.sarepta.com and will be archived there following the presentation for 90 days.
  • At Sarepta, we are leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with rare disease.
  • The Companys programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing.

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments on March 1, 2021

Retrieved on: 
Monday, February 22, 2021

CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2020 financial results after the Nasdaq Global Market closes on Monday, March 1, 2021.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2020 financial results after the Nasdaq Global Market closes on Monday, March 1, 2021.
  • E.T., the Company will host a conference call to discuss its fourth quarter and full year 2020 financial results and to provide a corporate update.
  • The conference call may be accessed by dialing (844) 534-7313 for domestic callers and (574) 990-1451 for international callers.
  • Please specify to the operator that you would like to join the "Sarepta Fourth Quarter and Full-Year 2020 Earnings Call."

Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition

Retrieved on: 
Thursday, February 4, 2021

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc.(NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the four winners of the Rare Lessons lesson planning competition.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc.(NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the four winners of the Rare Lessons lesson planning competition.
  • Sarepta has granted the winning authors $2,500 each and $2,500 to the educational institution with which each is affiliated.
  • Rare Lessons competition winners and lesson plan titles:
    Jessica Keogh, West Chester Area School District, Exton, Penn.
  • For the Rare Lessons contest, Sarepta partnered with sharemylesson.com , a platform that offers broad availability of lesson plans for educators and schools across the country.